CA2367396A1 - Methode de selection de variantes de recombinase a specificite modifiee - Google Patents
Methode de selection de variantes de recombinase a specificite modifiee Download PDFInfo
- Publication number
- CA2367396A1 CA2367396A1 CA002367396A CA2367396A CA2367396A1 CA 2367396 A1 CA2367396 A1 CA 2367396A1 CA 002367396 A CA002367396 A CA 002367396A CA 2367396 A CA2367396 A CA 2367396A CA 2367396 A1 CA2367396 A1 CA 2367396A1
- Authority
- CA
- Canada
- Prior art keywords
- recombination
- sites
- variant
- site
- recombination sites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
L'invention concerne des variantes de recombinase Cre augmentant la spécificité du site de recombinaison. Plus particulièrement, l'invention concerne des variantes servant de médiation dans la recombinaison entre des séquences autres que la séquence loxP et autres séquences du site lox sur lesquelles la recombinase Cre de type sauvage est active. En général, les variantes Cre de l'invention servent de médiation dans la recombinaison efficace entre les sites lox sur lesquels peut agir la Cre de type sauvage (désignés sous le nom de sites lox de type sauvage), entre des sites lox variants n'étant pas utilisés de manière efficace par la Cre de type sauvage (désignés sous le nom de sites lox variants), et entre un site lox sauvage et un site lox variant. L'invention concerne également des méthodes de recombinaison d'acides nucléiques à l'aide des variantes Cre de l'invention. Par exemple, ces variantes Cre peuvent être utilisées dans toute méthode ou technique dans lesquelles peut être utilisée la recombinase Cre (ou d'autres recombinases semblables telles que la FLP). De plus, les variantes Cre permettent d'effectuer des recombinaisons diverses. En effet, les variantes Cre permettent une recombinaison beaucoup plus efficace entre les sites lox de type sauvage et les sites lox variants. La commande d'une recombinaison de ce type permet de réaliser des recombinaisons séquentielles plus sophistiquées et d'obtenir des résultats impossibles à atteindre avec la recombinase Cre de type sauvage.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12797799P | 1999-04-06 | 1999-04-06 | |
US60/127,977 | 1999-04-06 | ||
PCT/US2000/009154 WO2000060091A2 (fr) | 1999-04-06 | 2000-04-06 | Methode de selection de variantes de recombinase a specificite modifiee |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2367396A1 true CA2367396A1 (fr) | 2000-10-12 |
Family
ID=22432967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002367396A Abandoned CA2367396A1 (fr) | 1999-04-06 | 2000-04-06 | Methode de selection de variantes de recombinase a specificite modifiee |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1169458A2 (fr) |
AU (1) | AU4205500A (fr) |
CA (1) | CA2367396A1 (fr) |
WO (1) | WO2000060091A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888732A (en) | 1995-06-07 | 1999-03-30 | Life Technologies, Inc. | Recombinational cloning using engineered recombination sites |
DE69836092T2 (de) | 1997-10-24 | 2007-05-10 | Invitrogen Corp., Carlsbad | Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen |
US6632980B1 (en) | 1997-10-24 | 2003-10-14 | E. I. Du Pont De Nemours And Company | Binary viral expression system in plants |
ATE443074T1 (de) | 1999-03-02 | 2009-10-15 | Life Technologies Corp | Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren |
WO2001005961A1 (fr) * | 1999-07-14 | 2001-01-25 | Clontech Laboratories, Inc. | Procedes faisant intervenir la recombinase pour la production de vecteurs d'expression et compositions permettant d'atteindre ce resultat |
US6746870B1 (en) | 1999-07-23 | 2004-06-08 | The Regents Of The University Of California | DNA recombination in eukaryotic cells by the bacteriophage PHIC31 recombination system |
ES2355493T3 (es) * | 2000-02-18 | 2011-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Recombinasas alteradas para la modificación del genoma. |
WO2002008409A2 (fr) | 2000-07-21 | 2002-01-31 | The United States Of America, As Represented By The Secretary Of Agriculture | Procedes de remplacement, transposition et empilage de l'adn dans des genomes eucaryotes |
US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
GB0029375D0 (en) * | 2000-12-01 | 2001-01-17 | Total Fina Elf | Substrate linked directed evolution (slide) |
US6977165B2 (en) | 2001-01-18 | 2005-12-20 | Clontech Laboratories, Inc. | Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same |
CA2441937A1 (fr) | 2001-05-30 | 2002-12-05 | Chromos Molecular Systems, Inc. | Plate-formes basees sur des chromosomes |
WO2005054438A2 (fr) | 2003-12-01 | 2005-06-16 | Invitrogen Corporation | Molecule d'acide nucleique contenant des sites de recombinaison et leurs procedes d'utilisation |
EP2067858A1 (fr) | 2007-12-07 | 2009-06-10 | Universidad de Sevilla | Modèles d'animaux pour maladies neurodégénératives |
ES2337973B8 (es) | 2008-05-16 | 2011-07-21 | Proyecto De Biomedicina Cima, S.L. | Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad. |
ES2523016B1 (es) | 2013-05-20 | 2015-09-09 | 3P Biopharmaceuticals | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
-
2000
- 2000-04-06 EP EP00921779A patent/EP1169458A2/fr not_active Withdrawn
- 2000-04-06 CA CA002367396A patent/CA2367396A1/fr not_active Abandoned
- 2000-04-06 AU AU42055/00A patent/AU4205500A/en not_active Abandoned
- 2000-04-06 WO PCT/US2000/009154 patent/WO2000060091A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000060091A2 (fr) | 2000-10-12 |
WO2000060091A3 (fr) | 2001-05-10 |
EP1169458A2 (fr) | 2002-01-09 |
AU4205500A (en) | 2000-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220162647A1 (en) | Method for inducing targeted meiotic recombinations | |
Thomason et al. | Gene insertion and replacement in Schizosaccharomyces pombe mediated by the Streptomyces bacteriophage φC31 site-specific recombination system | |
CA2367396A1 (fr) | Methode de selection de variantes de recombinase a specificite modifiee | |
CN110157726B (zh) | 植物基因组定点替换的方法 | |
EP1234022B1 (fr) | Recombinaison de l'adn dans des cellules eucaryotes par le systeme de recombinaison du bacteriophage phic31 | |
US6746870B1 (en) | DNA recombination in eukaryotic cells by the bacteriophage PHIC31 recombination system | |
JP2019514376A (ja) | 標的核酸の改変のための改善された方法 | |
US6734019B1 (en) | Isolated DNA that encodes an Arabidopsis thaliana MSH3 protein involved in DNA mismatch repair and a method of modifying the mismatch repair system in a plant transformed with the isolated DNA | |
JP2004504055A (ja) | 真核生物ゲノムにおけるdnaの置換、転座およびスタッキングの方法 | |
AU2005224324B2 (en) | Improved constructs for marker excision based on dual-function selection marker | |
US6890726B1 (en) | Method for selecting recombinase variants with altered specificity | |
JP2015535010A (ja) | 部位特異的酵素および使用方法 | |
CA2759882A1 (fr) | Nouveau procede de clonage de l'adn | |
WO2007000077A1 (fr) | Gène de riz cyp81a6 résistant aux herbicides bentazone et sulfonylurée | |
EP4242330A2 (fr) | Génération de maïs résistant à l'helminthosporiose du nord | |
EP3752619A1 (fr) | Procédés et compositions pour accroître le rendement des récoltes par édition des gènes de la ga20-oxydase et générer des plants de petite taille | |
US20030175968A1 (en) | Gene targeting method | |
CA2401677A1 (fr) | Procede de ciblage genique | |
CN112585272A (zh) | 基因靶向 | |
WO2019161147A1 (fr) | Procédés et compositions pour augmenter le rendement récoltable par l'édition de gènes de ga20 oxydase pour générer des plantes de petite taille | |
KR20190122595A (ko) | 식물의 염기 교정용 유전자 구조체, 이를 포함하는 벡터 및 이를 이용한 염기 교정 방법 | |
US8841511B2 (en) | Removal of plastid sequences by transiently expressed site-specific recombinases | |
EP1009843A1 (fr) | Expression selective des genes chez les vegetaux | |
JP4581838B2 (ja) | Dna断片連結方法及びキット | |
Thumasnn et al. | CELLS BY THE BACTERIOPHAGE PHIC31 RECOMBINATION SYSTEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |